A federal emergency declaration in January 2020 waived the requirement for health-care providers to meet patients in person before prescribing tightly regulated drugs. Once the emergency declaration expires, that practice could be in legal limbo.
The costs of COVID-19 vaccines are expected to skyrocket after the emergencies are lifted. Free at-home COVID tests will also come to an end. And hospitals will not get extra payments for treating COVID patients.
Federal watchdogs have been sounding the alarm for years about questionable charges on the private version of the Medicare program, with investigators raising the possibility that insurance companies may be bilking taxpayers of billions of dollars every year.
Jaypirca was approved to treat mantle cell lymphoma, or MCL. a rare blood cancer that starts in white blood cells in the lymph nodes for which there is no cure, according to Lilly. The disease affects about 1 in 200,000 people worldwide each year.
States all across the country are experiencing a shortage of home-health workers. It’s a problem that is not going away anytime soon.
Indiana’s mental health care system was created in a bygone era, and despite many efforts over many years, it is still problematic today.
It’s the latest in a series of bills meant to address the high cost of health care in Indiana, as well as the physician shortage and patients’ rights.
The boost in enrollment for the insurance marketplace comes as the number of uninsured people is at an all-time low. Just 8% of those in the United States remain without coverage.
A coalition of five agencies in Indiana that serve youth plans to use the grant to support the well-being of professionals in the industry.
The proposed change is designed to reduce the complexity of the vaccine regimen for the public, doctors and manufacturers. It also reflects a view that “chasing variants” with ever-changing booster formulations is ultimately futile.
Evidence showing that access to regulated cannabis can improve public health outcomes is getting harder to ignore.
Donanemab’s ability to rapidly remove amyloid beta from patients’ brains prevented the required number of patients from receiving the drug for a full 12 months, Lilly said, resulting in the FDA rejection.
Patients Choice Laboratories said Friday it was “appalled” by the comments of its employee, who sent a vulgar, threatening direct message to Democratic Rep. Eric Swalwell.
California on Thursday announced it will sue the companies that make and promote most of the nation’s insulin, accusing them of scheming to illegally increase the price of the drug.
Upset with what they say is the excessive cost of health care in Indiana, House Republicans want to levy fines against hospitals that charge more than 260% of what Medicare reimburses for services.
Indiana University Health said Monday the cost of its new downtown hospital complex will now top $4 billion, an increase of 60% over previous estimates, due to higher construction costs and a major increase in the number of patient rooms.
Drugstore chains are still trying to find enough employees to put a stop to temporary pharmacy closures.
The descendant of the omicron variant rose from barely 2 percent of U.S. cases at the start of December to more than 27 percent the first week of January, according to new estimates.
It’s the first drug that’s been convincingly shown to slow the decline in memory and thinking that define the disease. But the medication comes with downsides, including potentially serious side effects and the need for frequent drug infusions.
The longtime industry standard of negotiating hospital reimbursement as a discount on the hospital’s billed charges is being replaced with fixed rates based on what Medicare would pay for a given service.
